新诺威涨2.00%，成交额3.50亿元，主力资金净流出1994.79万元

Core Viewpoint - New Nuo Wei's stock price has shown fluctuations with a recent increase, while the company faces challenges in profitability despite revenue growth [1][2]. Financial Performance - As of January 6, New Nuo Wei's stock price was 38.20 CNY per share, with a market capitalization of 53.655 billion CNY [1]. - For the period from January to September 2025, the company achieved a revenue of 1.593 billion CNY, representing a year-on-year growth of 7.71%, but reported a net profit loss of 24.049 million CNY, a decrease of 117.26% compared to the previous year [2]. Shareholder Information - As of December 10, the number of shareholders increased to 24,300, up by 4.36%, while the average circulating shares per person decreased by 4.17% to 57,704 shares [2]. - Cumulative cash dividends since the A-share listing amount to 651 million CNY, with 500 million CNY distributed over the past three years [3]. Institutional Holdings - As of September 30, 2025, the second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 17.7822 million shares, a decrease of 3.2169 million shares from the previous period [3]. - Other notable shareholders include China Europe Medical Health Mixed A and Industrial Bank Frontier Medical Stock A, with varying changes in their holdings [3].